在肠道炎症中微生物衍生的抗氧化剂:对其治疗潜力的系统审查
María José García Mansilla1, María Jesús Rodríguez Sojo1,2, Andreea Roxana Lista2
1Department of Pharmacology, Centro de Investigación Biomédica (CIBM), University of Granada, 18071 Granada, Spain.
Antioxidants (Basel, Switzerland)
|April 14, 2025
概括
微生物抗氧化剂如外聚糖和短链脂肪酸可以通过中和氧化应激和改善肠道屏障功能来对抗炎症性肠病 (IBD) 中的肠道炎症.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 由活性氧物种 (ROS) 驱动的氧化应激,在炎症性肠病 (IBD) 中显著促进慢性肠炎症.
- 肠道功能障碍是IBD的常见特征,进一步加剧炎症过程.
- 目前的IBD治疗主要集中在免疫调节上,可能会忽视氧化应激和微生物失衡的作用.
研究的目的:
- 系统地审查微生物衍生抗氧化剂在缓解肠道炎症方面的作用和机制,特别是在IBD的背景下.
- 探索诸如外聚糖 (EPS) 和短链脂肪酸 (SCFA) 等化合物如何影响氧化应激和肠道屏障完整性.
- 评估微生物抗氧化剂作为IBD的补充治疗策略的潜力.
主要方法:
- 对临床前和临床研究的系统文献综述.
- 分析微生物衍生抗氧化剂中和ROS的机制.
- 对肠道屏障功能和肠道微生物群组成的影响的评估.
主要成果:
- 微生物衍生的抗氧化剂,包括外聚糖 (EPS) 和短链脂肪酸 (SCFA),有效中和活性氧物种 (ROS).
- 这些化合物增强肠道屏障的完整性,从而减少炎症反应.
- 微生物抗氧化剂具有减轻氧化应激和重新平衡肠道微生物群的双重好处,而肠道微生物群在IBD中经常受到破坏.
结论:
- 微生物衍生的抗氧化剂是传统IBD治疗的有希望的补充方法.
- 它们能够解决氧化损伤和肠道失调的能力提供了一个新的治疗途径.
- 需要进一步进行临床研究,以制定治疗指南并确认长期疗效.
关键词:
在SCFAs中,SCFAs是最重要的.这种疾病叫做dysbiosis.在这里,我们可以看到子子.这是一种炎症炎症炎症炎症.微生物衍生的抗氧化剂是微生物衍生的抗氧化剂.微生物组是一个微生物组.后生物学的后生物.更多相关视频
06:57Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
Published on: September 18, 2016
8.9K
07:34Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
2.4K
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
80
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
80
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
246
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
246
